Climb Bio, Inc.
CLYM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001768446
In the last 90 days, Climb Bio, Inc. insiders filed 0 open-market purchases and 1 sale; 108 institutions reported holding it in 13F filings for Q2 2026, worth $734.3M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Climb Bio, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 43 | 1 | 29 | −13 |
| Shares | 17.5M | 1.04K | 15.1M | −2.38M (−13.6%) |
| Value | $146.8M | $9.00K | $45.7M | −$101.1M (−68.9%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held Climb Bio, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 89,944 | $272.0K | 0.00% |
| Ergoteles LLC | 26,364 | $80.0K | 0.00% |
| Atom Investors LP | 26,309 | $79.0K | 0.03% |
| Citadel Advisors LLC | 15,211 | $46.0K | 0.00% |
| Credit Suisse AG | 3 | $0 | 0.00% |
Sold out (18)
Institutions that held Climb Bio, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Samlyn Capital, LLC | 2,130,237 | $17.9M |
| Monashee Investment Management LLC | 227,201 | $1.91M |
| Point72 Asset Management, L.P. | 142,333 | $1.19M |
| Hudson Bay Capital Management LP | 100,000 | $839.0K |
| Charles Schwab Investment Management Inc | 16,001 | $135.0K |
| Qube Research & Technologies Ltd | 15,874 | $133.0K |
| Bank of New York Mellon Corp | 13,893 | $117.0K |
| Deutsche Bank AG | 3,841 | $32.0K |
| American International Group, Inc. | 2,995 | $25.0K |
| JPMorgan Chase & Co | 2,829 | $24.0K |
| Barclays PLC | 2,850 | $24.0K |
| California State Teachers Retirement System | 2,593 | $22.0K |
| Allspring Global Investments Holdings, LLC | 2,400 | $20.0K |
| STRS Ohio | 1,600 | $13.0K |
| Amalgamated Bank | 1,039 | $9.00K |
| Ameritas Investment Partners, Inc. | 541 | $5.00K |
| Cubist Systematic Strategies, LLC | 638 | $5.00K |
| Point72 Hong Kong Ltd | 170 | $1.00K |
Not filed for Q2 2022 yet (1)
Institutions that held Climb Bio, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 1,039 | $9.00K |